HIV/AIDS Trials
Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.
Page 1 of 1 | Results 1 - 2 of 2
The purpose of this study is to compare safety, efficacy, and tolerability of a two drug regimen of dolutegravir (DTG) plus (+) lamivudine (3TC) administered once daily to the DTG plus Tenofovir [TDF]/Emtricitabine [FTC] fixed dose combination [FDC] administered once daily in human immunodeficiency virus (HIV) 1 infected adult subjects that have not previously received antiretroviral therapy. The study is designed to demonstrate the non-inferior antiviral activity of DTG plus 3TC regimen to that of DTG plus TDF/FTC FDC.
Dr. Daniel Skiest
Infection,
HIV
Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199
The purpose of this study is to test the efficacy of 4 mg Pitavastatin daily on cardiovascular-related events among HIV-1 infected adults.
Daniel J. Skiest, MD
HIV,
Heart
Baystate Infectious Diseases Clinical Research
3300 Main Street
Springfield, MA 01199
Page 1 of 1 | Results 1 - 2 of 2